AZD0284

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Plaque Psoriasis Vulgaris

Phase 1

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects

CompletedNCT02976831

AstraZenecaPlaque Psoriasis Vulgaris

Start: 2016-12-09End: 2017-05-30Updated: 2017-06-14

Bioavailability of AZD0284 and IV Microtracer Study

CompletedNCT03029741

AstraZenecaPlaque Psoriasis Vulgaris

Start: 2017-02-21End: 2017-03-23Updated: 2017-04-13